页面加载中...
   Tamoxifen citrate
   Product name   Tamoxifen citrate
   CAS No.   54965-24-1
   Molecular Structure   
   Uasage   

EINECS: 259-415-2
Molecular Formula: C26H29NO.C6H8O
Synonyms: Farmifeno; Oncomox; Tamoxifen citrate (JAN/USP); Tafoxen; Kessar; Tamoxasta; Tamoxifenum [INN-Latin]; Nolvadex (TN); Soltamox; Noxitem; Oncotam; Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl, (Z)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); Crisafeno; Nourytan; Tamoplex; Tamofen; ICI 46474; Tamax; Tamoxifene [INN-French]; Tamoxen; Nolvadex; Ethanamine,2-[4-[(1Z)-1,2-diphenyl-1- butenyl]phenoxy]-N,N-dimethyl-,2-hydroxy- 1,2,3-propanetricarboxylate (1:1); 2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethyl-ethanamine; 2-hydroxypropane-1,2,3-tricarboxylic acid; Valodex; Ethanamine, 2-[4- (1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethyl-, (Z)-, 2-hydroxy-1,2,3-propane-tricarboxylate (1:1);
Appearance: white to off-white powder
Molecular Weight: 563.64
Boiling Point: 665.9 °C at 760 mmHg
Melting Point: 140-144℃
Flash Point: 356.5 °C
Storage Temperature: 2-8°C
Solubility: slightly soluble
Biological Activity: Estrogen receptor antagonist/partial agonist. Selective and potent inhibitor of mammalian sterol isomerase. Neuroprotective in female rats in vivo . Also high affinity agonist at the membrane estrogen receptor GPR30.
Stability: Stable under normal temperatures and pressures.
Usage: A nonsteroidal antiestrogen. Used for treatemnt of advanced, metastatic breast cancer.


  .Remark: products patented are for R&D only and are permitted under 35 USC 271(e). 
  .Patent products cannot be offered to the countries where patent law is in force. 
   Final responsibility lies with the buyer exclusively.

  Contact Us: Pharmchem Devision:info@afinechem.com

                         Finechem Devision:sales@afinechem.com